VHL and nonpapillary renal cell carcinoma: Co-expression of VHL and p53 has been noted to lead to a higher rate of G0/G1 cell arrest and apoptosis in cell lines from ccRCC in ADM (Adriamycin) or sunitinib treatment [24].